Mothers of infants (N=205) Mothers of SCD affected children (N=181) χ2
1 Knowledge of hemoglobin genotype 156 (76.1%) 165 (91.2%) 16.1, P=0.001
2 Knowledge of spouse’s hemoglobin genotype 136 (66.3%) 163 (90.1%) 31.1, P=0.001
3 Awareness that sickle cell disease can be diagnosed in the new born period 88 (42.9%) 84 (46.4%) 1.68, P=0.43
4 Acceptance of screening newborn for SCD 133 (64.9%) 168 (92.8%) 42.9, P<0.001
5 Willingness to allow newborn baby remain in the birth facility for more than 24 hours for hemoglobin genotype test 113 (55.1%) 147 (81.2%) 28.8, P<0.001
6 Willingness to allow newborn baby have hemoglobin genotype test at the immunization center 154 (75.1%) 167 (92.3%) 18.2., P<0.001
7 Husband will be happy if mother permits hemoglobin genotype test on baby in the newborn period 133 (64.9%) 156 (86.2%) 27.8, P<0.001
8 Husband will be happy if mother permits hemoglobin genotype teston baby during an immunization visit 145 (70.7%) 159 (87.8%) 24.2, P<0.001
9 In need of permission of any family member to test baby’s hemoglobin genotype. 62 (30.2%) 16 (8.8%) 30.2, P<0.001
10 Acknowledgment of advantage in knowing the hemoglobin genotype of baby at birth 164 (80%) 158 (87.3%) 3.9, P=0.145
11 Acknowledgment that the best time to diagnose SCD is in the newborn period 110 (53.7%) 95 (52.5%) 2.42, P=0.298
12 Agreement that testing a baby in the newborn period for SCD is beneficial 153 (74.6%) 156 (86.2%) 11.42, P=0.003
13 Acknowledgment of disadvantages in testing a baby for SCD in the newborn period 17 (8.3%) 27 (14.9%) 17.60, P=0.001